ARRIVENT BIOPHARMA, INC. (AVBP) ROA
- 2026-06-30: ROA -41.48%.
- 2026-03-31: ROA -41.58%.
- 2025-12-31: ROA -49.92%.
- 2025-09-30: ROA -46.36%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -41.48% |
| 2026-03-31 | -41.58% |
| 2025-12-31 | -49.92% |
| 2025-09-30 | -46.36% |
| 2025-06-30 | -50.83% |
| 2025-03-31 | -59.15% |
| 2024-12-31 | -29.27% |
| 2024-09-30 | -27.69% |
| 2024-06-30 | -24.25% |
| 2024-03-31 | -22.75% |
| 2023-12-31 | -42.51% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -49.92% |
| 2024-12-31 | -29.27% |
| 2023-12-31 | -42.51% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |